Additional information

Laboratory

Exult Diagnostics, Dr. Lal PathLabs

Reviews

There are no reviews yet.

Be the first to review “PROSTATE HEALTH INDEX (PHI)”

Your email address will not be published. Required fields are marked *

PROSTATE HEALTH INDEX (PHI)

 2800

EX1753      PROSTATE HEALTH INDEX (PHI)
Specimen: 2 mL (1 mL min.) serum from 1 SST. Ship refrigerated or frozen.
Stability:
Room Refrigerated Frozen
2 hrs 24 hrs 4 weeks
Method: CMIA, CLIA
Comment: Samples received on holidays will be reported in the next schedule/next working day.
Report: Contact us to know the TAT.
Usage: Prostate health index (phi) combines three PSA forms (total PSA, free PSA, and p2PSA) into a single score. p2PSA test measures the [-2]proPSA concentration in serum, [-2]proPSA is one of the isoforms of free PSA and has been determined to be most specific to Prostate cancer. phi demonstrates a significant improvement in clinical specificity for prostate cancer detection, relative to PSA alone in men 50 years of age or older with a PSA range of 2-10 ng/mL and with non-suspicious digital rectal exam (DRE) findings. At 95% clinical sensitivity, the clinical specificity for phi is 18.2% as compared to 6.6% for percentage free PSA in the diagnostic grey zone. A low phi result indicates a lower risk of Prostate cancer, while an elevated phi result may suggest that a prostate biopsy is necessary to rule out cancer.
Doctor Specialty: Oncologist
Disease: Prostate Cancer
Components: *PSA, Total *PSA, Free *P2PSA
Courier Charges:
Home Collection: Available (*T&C Apply)
Department: Biochemistry
Pre Test Information: Do not give samples within 7 days of Digital Rectal Examination (DRE) or Rectal Prostatic Ultrasonography.